Peptide based metabolic disorders therapeutics market to reach $63.7 billion by 2030 at 13.0% cagr, driven by rising prevalence of obesity.
Read More
Global Nucleic Acid Labeling market size is expected to reach $4.42 billion by 2030 at 9.9%, nucleic acid labeling market surges amidst rising infectious diseases
Read More
Peptide antibiotics market to reach $9.04 billion by 2030 at 9.3% cagr, driven by increase in prevalence of infectious diseases.
Read More
Global Nucleic Acid And Gene Therapies In Neuromuscular Disorders market size is expected to reach $11.76 billion by 2030 at 9.4%, rising prevalence of genetic disorders fuels growth in the market
Read More
Peptide and oligonucleotide cdmo market to reach $4.03 billion by 2030 at 10.5% cagr, driven by growing adoption of personalized medicine.
Read More
The Nuclear Protein In Testis Midline Carcinoma Treatment market size is expected to reach $42.21 billion in 2030 at 13.6%, driven by growing adoption of personalized medicine.
Read More
Peptide and anticoagulant drugs market to reach $2.47 billion by 2030 at 9.9% cagr, driven by rising prevalence of chronic diseases.
Read More
The global pentavalent market to reach $3.39 billion by 2030 at 4.7% cagr, driven by rising prevalence of diphtheria.
Read More
Global Nuclear Medicine market size is expected to reach $17.13 billion by 2030 at 10.7%, cardiovascular disease and cancer surge drive growth in the nuclear medicine market
Read More
Pegfilgrastim biosimilars market to reach $2.65 billion by 2030 at 6.7% cagr, driven by increased incidence of cancer.
Read More